Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Short Interest Update

by · The Markets Daily

Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) saw a large decline in short interest during the month of August. As of August 31st, there was short interest totaling 643,675 shares, a decline of 92.1% from the August 15th total of 8,112,226 shares. Based on an average daily volume of 927,244 shares, the days-to-cover ratio is currently 0.7 days. Currently, 22.8% of the shares of the stock are sold short.

Analysts Set New Price Targets

GRML has been the subject of several analyst reports. Wall Street Zen raised shares of Greenland Mines Ltd. Common Stock to a “sell” rating in a research note on Saturday, August 29th. Weiss Ratings cut shares of Greenland Mines Ltd. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Get Our Latest Report on Greenland Mines Ltd. Common Stock

Greenland Mines Ltd. Common Stock Trading Down 8.8%

GRML traded down $0.37 on Thursday, hitting $3.82. 349,663 shares of the company were exchanged, compared to its average volume of 714,209. Greenland Mines Ltd. Common Stock has a twelve month low of $3.82 and a twelve month high of $36.99. The company has a market cap of $12.15 million, a price-to-earnings ratio of -0.33 and a beta of 6.91. The firm has a 50-day moving average price of $8.84 and a two-hundred day moving average price of $16.97.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) last issued its earnings results on Monday, August 17th. The company reported ($0.03) earnings per share for the quarter.

Insider Transactions at Greenland Mines Ltd. Common Stock

In related news, Director Riad Hussein El-Dada sold 3,500 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $11.50, for a total value of $40,250.00. Following the completion of the sale, the director owned 3,500 shares of the company’s stock, valued at approximately $40,250. This trade represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jeff Leblanc bought 14,000 shares of the business’s stock in a transaction on Tuesday, August 25th. The stock was bought at an average cost of $9.72 per share, with a total value of $136,080.00. Following the completion of the purchase, the chief financial officer directly owned 110,406 shares in the company, valued at approximately $1,073,146.32. The trade was a 14.52% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 11.30% of the company’s stock.

Institutional Trading of Greenland Mines Ltd. Common Stock

Several institutional investors have recently modified their holdings of GRML. Citadel Advisors LLC acquired a new position in Greenland Mines Ltd. Common Stock in the second quarter valued at $1,343,000. XTX Topco Ltd grew its holdings in shares of Greenland Mines Ltd. Common Stock by 101.2% during the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock worth $46,000 after purchasing an additional 80,768 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of Greenland Mines Ltd. Common Stock during the fourth quarter worth about $64,000. Renaissance Technologies LLC acquired a new stake in shares of Greenland Mines Ltd. Common Stock during the fourth quarter worth about $126,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Greenland Mines Ltd. Common Stock by 51.8% in the 4th quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after purchasing an additional 167,905 shares during the last quarter. Hedge funds and other institutional investors own 20.07% of the company’s stock.

Greenland Mines Ltd. Common Stock Company Profile

(Get Free Report)

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Featured Stories